Latest News

This meme coin made history with its explosive rally in 2021. Since then, the performance has been lackluster.

Data center operators question how they can secure adequate power. Oklo thinks it has the answer.

Fashion conglomerate G-III (NASDAQ:GIII) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 9% year on year to $988.6 million. The company’s full-year revenue guidance of $2.98 billion at the midpoint came in 1.3% below analysts’ estimates. Its non-GAAP profit of $1.90 per share was 17.9% above analysts’ consensus estimates.

Auto parts and accessories retailer AutoZone (NYSE:AZO) met Wall Streets revenue expectations in Q4 CY2025, with sales up 8.2% year on year to $4.63 billion. Its GAAP profit of $31.04 per share was 4.2% below analysts’ consensus estimates.

This stock already has advanced, but it has plenty of room to run.

Organizational consulting firm Korn Ferry (NYSE:KFY) announced better-than-expected revenue in Q3 CY2025, with sales up 7% year on year to $729.8 million. On the other hand, next quarter’s revenue guidance of $687 million was less impressive, coming in 1.4% below analysts’ estimates. Its non-GAAP profit of $1.33 per share was 1.4% above analysts’ consensus estimates.

The Federal Reserve is likely to cut interest rates this week, but investors will also watch policymakers for signs of division and concerns about stagflation.

If you're worried about a 2026 recession, start saving up three to six months' worth of living expenses in a high-yield savings account. Here's how to prepare.

A late-stage biotech with three pivotal trials underway just landed a major hedge-fund backer — here’s why the timing matters.

Amylyx Stock is up a staggering 166% over the past year, and this biotech-focused hedge fund is still doubling down.

Both of these coins are good for way more than processing payments.

If you qualify for this savings account, don't pass it up.

Footwear company Caleres (NYSE:CAL) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 6.6% year on year to $790.1 million. Its non-GAAP profit of $0.38 per share was 55.5% below analysts’ consensus estimates.

Intel stock has doubled this year, but the turnaround is only getting started.

Footwear and accessories discount retailer Designer Brands (NYSE:DBI) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 3.2% year on year to $752.4 million. Its non-GAAP profit of $0.38 per share was significantly above analysts’ consensus estimates.

Social media companies benefit from the lucrative user-generated content business model.

There are risks ahead for this still unproven quantum start-up.

CDs can have weaker long-term returns, taxes on interest, and rates that aren't always as "locked in" as they look. Here's how to navigate these challenges.

IRT’s fundamentals may be sturdier than its stock chart suggests — and one fund is making a sizable bet on that gap closing.

Is the demand for AI compute out of this world?

According to a CNBC report, Meta is now working on a next-generation AI project, codenamed Avocado, which is expected to launch in early 2026.

Water and fire protection solutions company Core & Main (NYSE:CNM) met Wall Streets revenue expectations in Q3 CY2025, with sales up 1.2% year on year to $2.06 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $7.65 billion at the midpoint. Its non-GAAP profit of $0.89 per share was 26% above analysts’ consensus estimates.

CareTrust REIT (CTRE) combines strong earnings growth, a top technical rating, and a high-quality breakout setup for momentum investors.

Elanco Animal Health CEO Jeff Simmons says the company is in the best position it's been in years. Elanco stock has surged.